Advertisement

Digestive Diseases and Sciences

, Volume 53, Issue 9, pp 2318–2329 | Cite as

Surgical Management of Gastroesophageal Reflux Disease in Obesity

  • Sayeed IkramuddinEmail author
Original Article

Abstract

Bariatric surgery is ubiquitous today. In the obese patient with comorbid gastroesophageal reflux disease (GERD), it is increasingly being used as an alternative to fundoplication because it not only has an effect on GERD but also on other comorbid illnesses. Traditional GERD surgery is designed to augment the mechanical barriers against reflux, decrease acid production in the stomach, improve gastric emptying, or divert bile from the stomach. Roux-en-Y gastric bypass addresses these issues in addition to resulting in profound weight loss in patients. Banding may have a positive influence in patients’ GERD, though to a lesser extent. The duodenal switch provides excellent control for patients with alkaline reflux. A revision of the 1991 National Institutes of Health guidelines for determining bariatric surgical candidates is overdue, and it may be feasible to consider expanding the body mass index and comorbidity requirements to reflect the benefits offered by these techniques for GERD patients.

Keywords

Gastroesophageal reflux disease Obesity Bariatric surgery Roux-en-Y Gastric bypass 

Notes

Acknowledgments

The author wish to thank Dr. Gonzalo Torres-Villalobos for his thoughtful review. The scientific roundtable was funded by Eisai, Inc. and PriCara, a Unit of Ortho-McNeil, Inc. International Meetings and Science, Inc. organized the roundtable and provided editorial support.

References

  1. 1.
    Scherer PE (2006) Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 55:1537–1545. doi: 10.2337/db06-0263 PubMedCrossRefGoogle Scholar
  2. 2.
    Greenberg AS, Obin MS (2006) Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr 83:461S–465SPubMedGoogle Scholar
  3. 3.
    Housa D, Housová J, Vernerová Z, Haluzík M (2006) Adipocytokines and cancer. Physiol Res 55:233–244PubMedGoogle Scholar
  4. 4.
    Barak N, Ehrenpreis ED, Harrison JR, Sitrin MD (2002) Gastro-oesophageal reflux disease in obesity: pathophysiological and therapeutic considerations. Obes Rev 3:9–15. doi: 10.1046/j.1467-789X.2002.00049.x PubMedCrossRefGoogle Scholar
  5. 5.
    Mercer CD, Wren SF, DaCosta LR, Beck IT (1987) Lower esophageal sphincter pressure and gastroesophageal pressure gradients in excessively obese patients. J Med 18:135–146PubMedGoogle Scholar
  6. 6.
    Wajed SA, Streets CG, Bremner CG, DeMeester TR (2001) Elevated body mass disrupts the barrier to gastroesophageal reflux. Arch Surg 136:1014–1018. doi: 10.1001/archsurg.136.9.1014 PubMedCrossRefGoogle Scholar
  7. 7.
    Kahrilas PJ, Pandolfino JE (2002) Gastroesophageal reflux disease and its complications, including Barrett’s metaplasia. In: Feldman M, Friedman LS, Sleisenger MH (eds) Gastrointestinal and liver disease: pathophysiology/diagnosis/management, 7th edn. Saunders, Philadelphia, pp 599–622Google Scholar
  8. 8.
    DeVault KR, Castell DO (2005) American College of Gastroenterology: updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol 100:190–200. doi: 10.1111/j.1572-0241.2005.41217.x PubMedCrossRefGoogle Scholar
  9. 9.
    DeMeester TR, Fuchs KH, Ball CS, Albertucci M, Smyrk TC, Marcus JN (1987) Experimental and clinical results with proximal end-to-end duodenojejunostomy for pathologic duodenogastric reflux. Ann Surg 206:414–426. doi: 10.1097/00000658-198710000-00003 PubMedCrossRefGoogle Scholar
  10. 10.
    Vakil N (2007) The role of surgery in gastro-oesophageal reflux disease. Aliment Pharmacol Ther 25:1365–1372PubMedGoogle Scholar
  11. 11.
    Spechler SJ, Lee E, Ahnen D, Goyal RK, Hirano I, Ramirez F et al (2001) Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial. JAMA 285:2331–2338. doi: 10.1001/jama.285.18.2331 PubMedCrossRefGoogle Scholar
  12. 12.
    Vakil N, Kirby R, Shaw M (2003) Clinical effectiveness of laparoscopic fundoplication in a US community. Am J Med 114:1–5. doi: 10.1016/S0002-9343(02)01390-6 PubMedCrossRefGoogle Scholar
  13. 13.
    Dominitz JA, Dire CA, Billingsley KG, Todd-Stenberg JA (2006) Complications and antireflux medication use after antireflux surgery. Clin Gastroenterol Hepatol 4:299–305. doi: 10.1016/j.cgh.2005.12.019 PubMedCrossRefGoogle Scholar
  14. 14.
    Madan A, Minocha A (2006) Despite high satisfaction, majority of gastro-oesophageal reflux disease patients continue to use proton pump inhibitors after antireflux surgery. Aliment Pharmacol Ther 23:601–605. doi: 10.1111/j.1365-2036.2006.02788.x PubMedCrossRefGoogle Scholar
  15. 15.
    Klaus A, Hinder RA, DeVault KR, Achem SR (2003) Bowel dysfunction after laparoscopic antireflux surgery: incidence, severity, and clinical course. Am J Med 114:6–9. doi: 10.1016/S0002-9343(02)01301-3 PubMedCrossRefGoogle Scholar
  16. 16.
    Lundell L, Miettinen P, Myrvold HE, Hatlebakk JG, Wallin L, Malm A et al (2007) Nordic GORD study group: seven-year follow-up of a randomized clinical trial comparing proton-pump inhibition with surgical therapy for reflux oesophagitis. Br J Surg 94:198–203. doi: 10.1002/bjs.5492 PubMedCrossRefGoogle Scholar
  17. 17.
    Mehta S, Bennett J, Mahon D, Rhodes M (2006) Prospective trial of laparoscopic nissen fundoplication versus proton pump inhibitor therapy for gastroesophageal reflux disease: seven-year follow-up. J Gastrointest Surg 10:1312–1316. doi: 10.1016/j.gassur.2006.07.010 PubMedCrossRefGoogle Scholar
  18. 18.
    Perez AR, Moncure AC, Rattner DW (2001) Obesity adversely affects the outcome of antireflux operations. Surg Endosc 15:986–989. doi: 10.1007/s004640000392 PubMedCrossRefGoogle Scholar
  19. 19.
    Morgenthal CB, Lin E, Shane MD, Hunter JG, Smith CD (2007) Who will fail laparoscopic Nissen fundoplication? Preoperative prediction of long-term outcomes. Surg Endosc 21:1978–1984. doi: 10.1007/s00464-007-9490-7 PubMedCrossRefGoogle Scholar
  20. 20.
    McNatt SS, Smith CD, Hunter JG et al (2000) Morbid obesity does not predict a poor outcome after laparoscopic antireflux surgery. Gastroenterology 118(suppl):SSAT A1033. Abstract 2260Google Scholar
  21. 21.
    D’Alessio MJ, Arnaoutakis D, Giarelli N, Villadolid DV, Rosemurgy AS (2005) Obesity is not a contraindication to laparoscopic Nissen fundoplication. J Gastrointest Surg 9:949–954. doi: 10.1016/j.gassur.2005.04.019 PubMedCrossRefGoogle Scholar
  22. 22.
    National Institutes of Health (1992) Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Statement. Am J Clin Nutr 55(suppl 2):6155–6195Google Scholar
  23. 23.
    Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K et al (2004) Bariatric surgery: a systematic review and meta-analysis. JAMA 292:1724–1737. doi: 10.1001/jama.292.14.1724 PubMedCrossRefGoogle Scholar
  24. 24.
    Balsiger BM, Poggio JL, Mai J, Kelly KA, Sarr MG (2000) Ten and more years after vertical banded gastroplasty as primary operation for morbid obesity. J Gastrointest Surg 4:598–605. doi: 10.1016/S1091-255X(00)80108-0 PubMedCrossRefGoogle Scholar
  25. 25.
    Ikramuddin S, Kendrick ML, Kellogg TA, Sarr MG (2007) Open and laparoscopic Roux-en-Y gastric bypass: our techniques. J Gastrointest Surg 11:217–228. doi: 10.1007/s11605-006-0028-4 Google Scholar
  26. 26.
    Schneider BE, Villegas L, Blackburn GL, Mun EC, Critchlow JF, Jones DB (2003) Laparoscopic gastric bypass surgery: outcomes. J Laparoendosc Adv Surg Tech A 13:247–255. doi: 10.1089/109264203322333575 PubMedCrossRefGoogle Scholar
  27. 27.
    Pories WJ, Swanson MS, MacDonald KG, Long SB, Morris PG, Brown BM et al (1995) Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 222:339–350. doi: 10.1097/00000658-199509000-00011 PubMedCrossRefGoogle Scholar
  28. 28.
    Buchwald H, Ikramuddin S (2002) Laparoscopic adjustable gastric banding in bariatric surgery: an overview of the LAP-BAND: introduction. Am J Surg 184:1S–3S. doi: 10.1016/S0002-9610(02)01171-6 PubMedCrossRefGoogle Scholar
  29. 29.
    Schauer PR, Ikramuddin S, Gourash W, Ramanathan R, Luketich J (2000) Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann Surg 232:515–529. doi: 10.1097/00000658-200010000-00007 PubMedCrossRefGoogle Scholar
  30. 30.
    Schauer PR, Burguera B, Ikramuddin S, Cottam D, Gourash W, Hamad G et al (2003) Effect of laparoscopic Roux-en Y bypass on type 2 diabetes mellitus. Ann Surg 238:467–484PubMedGoogle Scholar
  31. 31.
    Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, Dellinger EP et al (2002) Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 346:1623–1630. doi: 10.1056/NEJMoa012908 PubMedCrossRefGoogle Scholar
  32. 32.
    Whitson BA, Leslie DB, Kellogg TA, Maddaus MA, Buchwald H, Billington CJ et al (2007) Entero-endocrine changes after gastric bypass in diabetic and nondiabetic patients: a preliminary study. J Surg Res 141:31–39. doi: 10.1016/j.jss.2007.02.022 PubMedCrossRefGoogle Scholar
  33. 33.
    Greenway SE, Greenway FL 3rd, Klein S (2002) Effects of obesity surgery on non-insulin-dependent diabetes mellitus. Arch Surg 137:1109–1117. doi: 10.1001/archsurg.137.10.1109 PubMedCrossRefGoogle Scholar
  34. 34.
    Ballantyne GH (2006) Peptide YY(1-36) and peptide YY(3-36): part I. Distribution, release and actions. Obes Surg 16:651–658. doi: 10.1381/096089206776944959 PubMedCrossRefGoogle Scholar
  35. 35.
    Ballantyne GH (2006) Peptide YY(1-36) and peptide YY(3-36): part II. Changes after gastrointestinal surgery and bariatric surgery. Obes Surg 16:795–803. doi: 10.1381/096089206777346619 PubMedCrossRefGoogle Scholar
  36. 36.
    Ballantyne GH, Farkas D, Laker S, Wasielewski A (2006) Short-term changes in insulin resistance following weight loss surgery for morbid obesity: laparoscopic adjustable gastric banding versus laparoscopic Roux-en-Y gastric bypass. Obes Surg 16:1189–1197. doi: 10.1381/096089206778392158 PubMedCrossRefGoogle Scholar
  37. 37.
    Rubino F, Marescaux J (2004) Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg 239:1–11. doi: 10.1097/01.sla.0000102989.54824.fc PubMedCrossRefGoogle Scholar
  38. 38.
    Mattar SG, Qureshi F, Taylor D, Schauer PR (2006) Treatment of refractory gastroesophageal reflux disease with radiofrequency energy (Stretta) in patients after Roux-en-Y gastric bypass. Surg Endosc 20:850–854. doi: 10.1007/s00464-006-0513-6 PubMedCrossRefGoogle Scholar
  39. 39.
    Smith CD, Herkes SB, Behrns KE, Fairbanks VF, Kelly KA, Sarr MG (1993) Gastric acid secretion and vitamin B12 absorption after vertical Roux-en-Y gastric bypass for morbid obesity. Ann Surg 218:91–96. doi: 10.1097/00000658-199307000-00014 PubMedCrossRefGoogle Scholar
  40. 40.
    Johnson WH, Fernanadez AZ, Farrell TM, Macdonald KG, Grant JP, McMahon RL et al (2007) Surgical revision of loop (“mini”) gastric bypass procedure: multicenter review of complications and conversions to Roux-en-Y gastric bypass. Surg Obes Relat Dis 3:37–41. doi: 10.1016/j.soard.2006.09.012 PubMedCrossRefGoogle Scholar
  41. 41.
    Smith SC, Edwards CB, Goodman GN (1997) Symptomatic and clinical improvement in morbidly obese patients with gastroesophageal reflux disease following Roux-en-Y gastric bypass. Obes Surg 7:479–484. doi: 10.1381/096089297765555205 PubMedCrossRefGoogle Scholar
  42. 42.
    Jones KB Jr (1998) Roux-en-Y gastric bypass: an effective antireflux procedure in the less than morbidly obese. Obes Surg 8:35–38. doi: 10.1381/096089298765555024 PubMedCrossRefGoogle Scholar
  43. 43.
    Frezza EE, Ikramuddin S, Gourash W, Rakitt T, Kingston A, Luketich J et al (2002) Symptomatic improvement in gastroesophageal reflux disease (GERD) following laparoscopic Roux-en-Y gastric bypass. Surg Endosc 16:1027–1031. doi: 10.1007/s00464-001-8313-5 PubMedCrossRefGoogle Scholar
  44. 44.
    Dixon JB, O’Brien PE (1999) Gastroesophageal reflux in obesity: the effect of lap-band placement. Obes Surg 9:527–531. doi: 10.1381/096089299765552602 PubMedCrossRefGoogle Scholar
  45. 45.
    Patterson EJ, Davis DG, Khajanchee Y, Swanström LL (2003) Comparison of objective outcomes following laparoscopic Nissen fundoplication versus laparoscopic gastric bypass in the morbidly obese with heartburn. Surg Endosc 17:1561–1565. doi: 10.1007/s00464-002-8955-y PubMedCrossRefGoogle Scholar
  46. 46.
    Ryden A, Torgerson JS (2006) The Swedish obese subjects study—what has been accomplished to date? Surg Obes Relat Dis 2:549–560. doi: 10.1016/j.soard.2006.07.006 PubMedCrossRefGoogle Scholar
  47. 47.
    Christou NV, Sampalis JS, Liberman M, Look D, Augur S, McLean AP et al (2004) Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg 240:416–423. doi: 10.1097/01.sla.0000137343.63376.19 PubMedCrossRefGoogle Scholar
  48. 48.
    Sjöström L, Narbro K, Sjöström CD, Karason K, Larsson B, Wede IH et al (2007) Swedish obese subjects study: effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 357:741–752. doi: 10.1056/NEJMoa066254 PubMedCrossRefGoogle Scholar
  49. 49.
    Adams TD, Gress RE, Smith SC, Halverson RC, Simper SC, Rosamond WD et al (2007) Long-term mortality after gastric bypass surgery. N Engl J Med 357:753–761. doi: 10.1056/NEJMoa066603 PubMedCrossRefGoogle Scholar
  50. 50.
    Horgan S, Pohl D, Bogetti D, Eubanks T, Pellegrini C (1999) Failed antireflux surgery: what have we learned from reoperations? Arch Surg 134:809–815. doi: 10.1001/archsurg.134.8.809 PubMedCrossRefGoogle Scholar
  51. 51.
    Soper NJ, Dunnegan D (1999) Anatomic fundoplication failure after laparoscopic antireflux surgery. Ann Surg 229:669–676. doi: 10.1097/00000658-199905000-00009 PubMedCrossRefGoogle Scholar
  52. 52.
    Wilson LJ, Ma W, Hirschowitz BI (1999) Association of obesity with hiatal hernia and esophagitis. Am J Gastroenterol 94:2840–2844. doi: 10.1111/j.1572-0241.1999.01426.x PubMedCrossRefGoogle Scholar
  53. 53.
    Pandolfino JE, El-Serag HB, Zhang Q, Shah N, Ghosh SK, Kahrilas PJ (2006) Obesity: a challenge to esophagogastric junction integrity. Gastroenterology 130:639–649. doi: 10.1053/j.gastro.2005.12.016 PubMedCrossRefGoogle Scholar
  54. 54.
    Hunter JG, Smith CD, Branum GD, Waring JP, Trus TL, Cornwell M et al (1999) Laparoscopic fundoplication failures: patterns of failure and response to fundoplication revision. Ann Surg 230:595–604. doi: 10.1097/00000658-199910000-00015 PubMedCrossRefGoogle Scholar
  55. 55.
    Kellogg TA, Andrade R, Maddaus M, Slusarek B, Buchwald H, Ikramuddin S (2007) Anatomic findings and outcomes after antireflux procedures in morbidly obese patients undergoing laparoscopic conversion to Roux-en-Y gastric bypass. Surg Obes Relat Dis 3:52–57. doi: 10.1016/j.soard.2006.08.011 PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  1. 1.Department of Surgery, Bariatric DivisionUniversity of MinnesotaMinneapolisUSA

Personalised recommendations